Sponsors

Paige to collaborate with Microsoft on AI for cancer diagnostics and treatment

US-based digital pathology and artificial intelligence (AI) firm Paige has announced a collaboration with Microsoft to apply the power of AI to digital pathology images to develop and deliver a new generation of clinical applications and computational biomarkers to transform cancer diagnosis and patient care.

Microsoft will also make a strategic investment in Paige to accelerate the development and deployment of life-saving AI diagnostics. Through the collaboration, Paige and Microsoft will scale Paige’s technology globally and accelerate the adoption of AI in digital pathology.

Paige will use Microsoft Azure as its cloud provider for the Paige Platform, a solution to power a laboratory’s digital pathology workflow that consists of data management, cloud storage options and FullFocus, an FDA-cleared whole-slide image viewer. As part of this collaboration, Paige will become a Microsoft Cloud for Healthcare partner and enable Microsoft to enhance its own offerings for healthcare customers.

Clinical AI applications have the potential to help pathologists diagnose cancer more confidently and efficiently, with the ultimate goal of improving patient care. Paige is currently the only company to have received FDA approval for an AI algorithm in pathology. Paige will work with other entities, including Microsoft Research on developing large scale machine learning models to push the boundaries of research in oncology and pathology. Paige is also working with Nuance, a Microsoft company, on integrating its offering with Nuance’s Precision Imaging Network.

“We are thrilled to partner with Microsoft to make AI cancer diagnostics accessible to countless laboratories and hospitals around the world as part of the digital transformation of pathology,” said Andy Moye, PhD, Chief Executive Officer at Paige. “We believe that Microsoft’s world-class AI resources, cloud infrastructure, global reach and scale, combined with our deep expertise in developing AI cancer diagnostics, will drive a new era of diagnostics and precision treatment to improve the lives of patients.”

Paige technology will be offered as a partner solution in Microsoft Cloud for Healthcare, expanding access to cutting-edge digital cancer diagnostic tools.  Microsoft Cloud for Healthcare connects customers with trusted partner solutions that make it easier to create personalised patient experiences, give clinicians connected tools, and adopt data standards important to healthcare. Together with Nuance, healthcare organisations can access the broadest and deepest set of trusted AI solutions to address the biggest challenges in the industry.

For additional information, please visit: https://www.paige.ai

 

Latest Issues

The Festival of Genomics and Biodata

ExCeL, London Docklands,
29-30 January 2025

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025